Literature DB >> 8033034

Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States, 1973-1987.

H I Goldberg1, S A Lockwood, S W Wyatt, L S Crossett.   

Abstract

BACKGROUND: This analysis consisted of an examination of trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States for a recent 15-year period.
METHODS: The authors have used national cause-of-death data for the United States and intercensal population estimates to examine mortality from oral and pharyngeal cancers between 1973 and 1987 and to study differentials according to gender, race, and region of residence.
RESULTS: The overall mortality rate from these cancers decreased by 19% during the 15-year period, with most of the decline occurring after 1979. Mortality was much higher for men than for women and for blacks than for whites throughout the interval. Despite the overall decline, mortality rates increased among blacks, especially among black men. Mortality was highest in the South Atlantic, New England, and Mid-Atlantic states and lowest in the Mountain states.
CONCLUSIONS: The disparity between male and female mortality from oral and pharyngeal cancer stems mainly from differences in the likelihood of developing these cancers, whereas the differences between blacks and whites appears to arise more from differences in survival than in incidence. Different age patterns of mortality for blacks and whites exist, in which mortality among whites, but not among blacks, rises continuously with age. An unexplained finding was that mortality rates were reported to have fallen in recent years, whereas incidence and survival rates have reportedly remained almost unchanged. This apparent inconsistency may have resulted from declines in the incidence of oral and pharyngeal cancers that have been masked by improved detection.

Entities:  

Mesh:

Year:  1994        PMID: 8033034     DOI: 10.1002/1097-0142(19940715)74:2<565::aid-cncr2820740206>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

2.  Telomere dysfunction promotes metastasis in a TERC null mouse model of head and neck cancer.

Authors:  Bojana Bojovic; David L Crowe
Journal:  Mol Cancer Res       Date:  2011-05-18       Impact factor: 5.852

3.  No evidence of sex-related survival disparities among head and neck cancer patients receiving similar multidisciplinary care: a matched-pair analysis.

Authors:  Jess C Roberts; Guojun Li; Lorraine R Reitzel; Qingyi Wei; Erich M Sturgis
Journal:  Clin Cancer Res       Date:  2010-10-13       Impact factor: 12.531

4.  A qualitative study of head and neck cancer.

Authors:  R J Moore; R M Chamberlain; F R Khuri
Journal:  Support Care Cancer       Date:  2004-04-03       Impact factor: 3.603

5.  Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro.

Authors:  Daisuke Sano; Fumihiko Matsumoto; David R Valdecanas; Mei Zhao; David P Molkentine; Yoko Takahashi; Ehab Y Hanna; Vali Papadimitrakopoulou; John Heymach; Luka Milas; Jeffrey N Myers
Journal:  Clin Cancer Res       Date:  2011-02-24       Impact factor: 12.531

6.  Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model.

Authors:  Daisuke Sano; David R Fooshee; Mei Zhao; Genevieve A Andrews; Mitchell J Frederick; Chad Galer; Zvonimir L Milas; Phuong Khanh H Morrow; Jeffrey N Myers
Journal:  Head Neck       Date:  2011-03       Impact factor: 3.147

7.  Prognostic significance of the tumour-adjacent tissue in head and neck cancers.

Authors:  Martina Raudenska; Marketa Sztalmachova; Jaromir Gumulec; Michaela Fojtu; Hana Polanska; Jan Balvan; Marek Feith; Hana Binkova; Zuzana Horakova; Rom Kostrica; Rene Kizek; Michal Masarik
Journal:  Tumour Biol       Date:  2015-07-14

8.  The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects.

Authors:  D L Mager; A D Haffajee; P M Devlin; C M Norris; M R Posner; J M Goodson
Journal:  J Transl Med       Date:  2005-07-07       Impact factor: 5.531

9.  A novel orthotopic mouse model of head and neck cancer and lymph node metastasis.

Authors:  R Masood; C Hochstim; B Cervenka; S Zu; S K Baniwal; V Patel; A Kobielak; U K Sinha
Journal:  Oncogenesis       Date:  2013-09-09       Impact factor: 7.485

10.  Prognostic factors associated with the survival of oral and pharyngeal carcinoma in Taiwan.

Authors:  Ping-Ho Chen; Tien-Yu Shieh; Pei-Shan Ho; Chi-Cheng Tsai; Yi-Hsin Yang; Ying-Chu Lin; Min-Shan Ko; Pei-Chien Tsai; Shang-Lun Chiang; Hung-Pin Tu; Ying-Chin Ko
Journal:  BMC Cancer       Date:  2007-06-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.